Savara Inc. (SVRA) — Stock Score Summary

Savara Inc. (SVRA) has a MoatMap StockRank of 24/100 based on Quality (30/100), Value (35/100), and Momentum (46/100) factor scores. The current signal is SELL. Savara is a clinical-stage biopharmaceutical company. It does not fit our CDMO pricing power theme as it is a drug developer rather than a manufacturing partner, exposing us to binary clinical trial risks.

Savara Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for rare respiratory diseases. Its lead candidate, molgramostim, is an inhaled biologic currently in late-stage clinical development for autoimmune pulmonary alveolar proteinosis (aPAP), a severe and life-threatening lung condition. The company operates as a niche player focused on orphan diseases, aiming to address significant unmet medical needs within these specialized markets.

Key Financial Metrics

Price$4.93
Market Cap$1.0B
P/E (Forward)-18.03
Price/Book6.61
Return on Equity-80.0%
Return on Invested Capital-52.7%
Debt/Equity17.11
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-58M

Savara Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Savara Inc.’s (SVRA) StockRank?
MoatMap’s StockRank for Savara Inc. (SVRA) is 24/100, with a Sell signal. It is a composite of Quality (30), Value (35), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does Savara Inc. have an economic moat?
Savara Inc. (SVRA) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Savara Inc. a buy, hold, or sell?
MoatMap’s current signal for Savara Inc. (SVRA) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Savara Inc. in?
Savara Inc. (SVRA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSVRA deep dive reportAI ChampionsHow we score stocksSense-check another stock